 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)品 > 美國(guó)藥典 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：A656510 |
| 產(chǎn)品名稱：Anamorelin |
| 產(chǎn)品CAS：249921-19-5 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
A656510 |
| 名稱: |
Anamorelin |
| 別名: |
2-Amino-N-[(1R)-2-{(3R)-3-benzyl-3-[(1,2,2-trimethylhydrazino)carbonyl]-1-piperidinyl}-1-(1H-indol-3-ylmethyl)-2-oxoethyl]-2-methylpropanamide; RC 1291; (3R)-1-(2-Methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic Acid 1,2,2-trimethylhydrazide |
| CAS號(hào): |
249921-19-5 |
| 分子式: |
C??H??N?O? |
| 外觀: |
白色至白色固體 |
| 熔點(diǎn): |
132-134°C |
| 分子量: |
546.7 |
| 儲(chǔ)存: |
冰箱保存 |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Anamorelin functions as a novel therapeutic options for cachexia and sarcopenia. Cancer cachexia and clinical therapeutic interventions. |
| 文獻(xiàn) |
|
|
|
|
|
|
|
|
